
Pulmotect
Clinical stage biotech company, developing products that boost the innate immune system to protect against a wide range of lung infections.
Employees
Enterprise value
$24—35m
Authorizing premium user...
Clinical stage biotech company, developing products that boost the innate immune system to protect against a wide range of lung infections.